OpenAlex
PricingAboutJobs
Log inGet started
Work

Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a

HTML

Year: 2012
Type: article
Source: Journal of Hepatology
DOI: 10.1016/j.jhep.2011.12.007
Authors: Vincent Rijckborst, Bettina E. Hansen, Peter Ferenci, Maurizia R. Brunetto, Fehmi Tabak, Yilmaz Cakaloglu, A. Galeota Lanza, Vincenzo Messina, Claudio Iannacone, Benedetta Massetto, Loredana Regep, Massimo Colombo, Harry L.A. Janssen, Pietro Lampertico
Institutions: Erasmus MC, Medical University of Vienna, Azienda Ospedaliera Universitaria Pisana, Istanbul University-Cerrahpaşa, Istanbul University, Ospedale Antonio Cardarelli, Roche (Italy), F. Hoffmann-La Roche AG, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Language: English

Topic: Hepatitis B Virus Studies
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Keywords: HBeAg-negative hepatitis B, peginterferon alfa-2a, stopping rules, HBsAg decline, sustained virological response, treatment duration, HBV genotypes, negative predictive value
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1978921235
FWCI: 18.86
Cites: 25
Cited by: 180
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms